Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: 1-Piperazineethanol, a-[(4-aminophenoxy)methyl]-4-phenyl-
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang

64511-27-9

64511-27-9 structure

64511-27-9 structure

Name: 1-Piperazineethanol, a-[(4-aminophenoxy)methyl]-4-phenyl-
Chemical Name: 1-(4-aminophenoxy)-3-(4-phenylpiperazin-1-yl)propan-2-ol
CAS Number: 64511-27-9
Molecular Formula: C₁₉H₂₅N₃O₂
Molecular Weight: 327.42100
Create Date: 2017-09-26 06:35:16
Modify Date: 2024-09-12 11:53:10

Name	1-(4-aminophenoxy)-3-(4-phenylpiperazin-1-yl)propan-2-ol

Density	1.188g/cm3
Boiling Point	554.4ºC at 760 mmHg
Molecular Formula	C₁₉H₂₅N₃O₂
Molecular Weight	327.42100
Flash Point	289.1ºC
Exact Mass	327.19500
PSA	61.96000
LogP	2.41480
Index of Refraction	1.613

CHEMICAL IDENTIFICATION

RTECS NUMBER :: TL6844630

CHEMICAL NAME :: 1-Piperazineethanol, alpha-((4-aminophenoxy)methyl)-4-phenyl-

CAS REGISTRY NUMBER :: 64511-27-9

BEILSTEIN REFERENCE NO. :: 0565708

LAST UPDATED :: 199612

DATA ITEMS CITED :: 1

MOLECULAR FORMULA :: C19-H25-N3-O2

MOLECULAR WEIGHT :: 327.47

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 400 mg/kg

TOXIC EFFECTS :: Behavioral - somnolence (general depressed activity) Behavioral - changes in motor activity (specific assay) Behavioral - alteration of classical conditioning

REFERENCE :: IJSBDB Indian Journal of Chemistry, Section B: Organic Chemistry, Including Medicinal Chemistry. (Publications & Information Directorate, Council of Scientific and Industrial Research (CSIR), Hillside Rd., New Delhi 110 012, India) V.14B- 1976- Volume(issue)/page/year: 15,466,1977

64511-26-8 structure

64511-26-8

~%

64511-27-9 structure

64511-27-9

Literature: Connors, Sean P.; Dennis, Paul D.; Gill, Edward W.; Terrar, Derek A. Journal of Medicinal Chemistry, 1991 , vol. 34, # 5 p. 1570 - 1577

110808-00-9 structure

110808-00-9

~66%

64511-27-9 structure

64511-27-9

Literature: Glozman, O. M.; Orlova, E. K.; Agavelyan, E. S.; Ismailov, Sh. I.; Nerobkova, L. N.; et al. Pharmaceutical Chemistry Journal, 1987 , vol. 21, # 3 p. 197 - 200 Khimiko-Farmatsevticheskii Zhurnal, 1987 , vol. 21, # 3 p. 309 - 312

100-02-7 structure

100-02-7

~%

64511-27-9 structure

64511-27-9

Literature: Connors, Sean P.; Dennis, Paul D.; Gill, Edward W.; Terrar, Derek A. Journal of Medicinal Chemistry, 1991 , vol. 34, # 5 p. 1570 - 1577

125228-75-3 structure

125228-75-3

~%

64511-27-9 structure

64511-27-9

Literature: Connors, Sean P.; Dennis, Paul D.; Gill, Edward W.; Terrar, Derek A. Journal of Medicinal Chemistry, 1991 , vol. 34, # 5 p. 1570 - 1577

Precursor 3
64511-26-8 110808-00-9 100-02-7
DownStream 1
64511-28-0